FIELD: medicine. SUBSTANCE: invention describes Ganoderma lucidum IV 009 strain which produces proteoglycane G009 having antitumor and immune-stimulating activity. Culture medium for cultivation contains β-glucose, a-glycose, galactose, a-mannose and fructose as saccharides; glycine, alamine, histidine, arginine, asparginic acid, isoleucine, serine, glutamic acid, thyrosine, proline, phenylanine and methionine as protein components. EFFECT: improved properties. 3 dwg, 15 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF MATRIX METALLOPROTEINASES | 2002 |
|
RU2283125C2 |
| DERIVATIVES OF 5-PYRROLYL-2-PYRIDYLMETHYLSULFONYLBENZIMIDAZOLE OR THEIR SALTS AND A METHOD OF THEIR SYNTHESIS | 1995 |
|
RU2100358C1 |
| METHOD OF PRODUCING LYMPHOCYTES CYTO-TOXIC TO CANCER CELLS, AND METHOD OF PRODUCING GLYCO-BOUND SUBSTANCE | 0 |
|
SU1412596A3 |
| CYCLOSPORINE | 1991 |
|
RU2085589C1 |
| ANTIALLERGIC PHARMACEUTICAL COMPOSITION FOR LOCAL OCULAR APPLICATION AND METHOD FOR ITS PRODUCTION | 1994 |
|
RU2107497C1 |
| COMBINATION OF TRADITIONAL CHINESE MEDICINE FOR IMMUNE FUNCTION REGULATION AND METHOD FOR ITS PRODUCTION | 2013 |
|
RU2630056C2 |
| LACTOBACILLUS RHAMNOSUS RHT-3201 CONJUGATED WITH POLYSACCHARIDE POLYMER BINDER, AND USE THEREOF FOR PREVENTION OR TREATMENT OF ATOPIC DISEASES | 2015 |
|
RU2671209C2 |
| METHOD FOR PRODUCING AGENT SHOWING ANTICANCER ACTIVITY, AND AGENT PRODUCED BY THIS METHOD (VERSIONS) | 2009 |
|
RU2416418C1 |
| COMPOSITION FOR TOPICAL USAGE CONTAINING HUMAN EPIDERMIS FACTOR GROWTH | 1998 |
|
RU2202362C2 |
| DERIVATIVES OF PYRIDONE CARBOXYLIC ACID, METHODS OF THEIR SYNTHESIS, ANTITUMOR AGENT AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2151770C1 |
